Publications by authors named "The Diabetes Subpanel of the National Lipid Association Expert Panel"
J Clin Lipidol
December 2014
Article Synopsis
- Statin therapy effectively lowers the risk of heart attacks, strokes, and cardiovascular death by 25% to 30%, making it the preferred treatment for high cholesterol.
- In 2012, the FDA updated statin labels to note a slight increase in the risk of developing type 2 diabetes, raising concerns about the balance of benefits and risks for diabetic patients or those at risk.
- The National Lipid Association's 2014 report recommends continuing statin use due to its cardiovascular benefits, but advises monitoring blood sugar levels in patients at higher risk for diabetes, while following established guidelines for diabetes screening and prevention.
